NuVasive Announces $154.4M Revenue for 2Q, Up 16.1%

NuVasive, a medical device company focused on minimally disruptive surgical products and procedures for the spine, announced revenue of $154.4 million for the second quarter this year, up 16.1 percent from the same period in 2011.

Advertisement

The second quarter revenues also indicate a 1.8 percent increase over the $151.7 million reported for the first quarter 2012. Gross profit for the second quarter 2012 was $117.9 million and gross margin was 76.3 percent, compared to a gross profit of $107.5 million and a gross margin of 80.8 percent for the second quarter last year.

The company also reported higher operating expenses for the second quarter 2012 of $104.9 million compared to $96.0 million in the second quarter last year. The higher operating expenses stemmed from additional costs associated with higher revenue and infrastructure expansion.

More Articles on Orthopedic Devices:

Minimally Invasive Surgery Market to Reach $35.5B by 2016

MiMedx Revenues Reach $4.9M in 2Q, 153% Increase

China Device Market Expected Grew at 20.5% CAGR From 2006-2011

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.